Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis
British Journal of Surgery · 2025
DOI: 10.1093/bjs/znaf153 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Surgery, 2025. Verfasst von Julia E Menso und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Robotic Surgical Procedures, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DIPLOMA-2 × 2, Intuitive Foundation, KWF Dutch Cancer Society.
Abstract (Originalsprache)
Background
Robot-assisted pancreatoduodenectomy (RPD) aims to enhance postoperative recovery compared to open pancreatoduodenectomy (OPD). Although recent randomized trials confirmed the short-term safety of RPD, they did not confirm superiority or assess oncological safety. This nationwide observational cohort study compares oncological outcome after RPD versus OPD in patients with resectable pancreatic ductal adenocarcinoma (PDAC) and distal cholangiocarcinoma (DCC) without vascular contact.
Methods
All consecutive patients undergoing RPD and OPD for upfront resectable PDAC and DCC without vascular contact on preoperative imaging in the Netherlands were included. Data were obtained from the Netherlands Cancer Registry (2016–2023). Primary outcomes were overall survival (OS) and R0-resection rate.
Results
Overall, 1675 patients after pancreatoduodenectomy for upfront resectable PDAC and DCC were included (375 RPD; 1300 OPD). Adjusted median OS was 23 months after RPD versus 22 months after OPD, with comparable 5-year survival rate (23.3% versus 22.4%, HR 0.96 [0.82–1.14], P = 0.665). The R0-resection rate was comparable (57.1% versus 59.7%, P = 0.368). RPD was associated with a shorter hospital stay (median 9 versus 11 days, P < 0.001) and comparable in-hospital/30-day (3.1% versus 2.6%, P = 0.618) and 90-day mortality rate (7.7% versus 6.2%, P = 0.276). In patients with PDAC, no differences in receipt (58.2% versus 58.7%, P = 0.900), time to start (median 54 versus 58 days, P = 0.107), or completion of adjuvant chemotherapy (30.4% versus 30.4%, P = 0.999) were observed.
Conclusions
In this nationwide study, oncological outcome including 5-year survival was comparable between patients undergoing RPD and OPD for upfront resectable PDAC and DCC without vascular contact without differences in the use of adjuvant therapy for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Amsterdam, The Netherlands.
- Department of Surgery, Amsterdam UMC, location Vrije Universiteit, Amsterdam, The Netherlands.
- Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
- Department of Pathology, Regional Academic Cancer Center Utrecht (RAKU), UMC Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Julia E Menso, Caro L Bruna, Mahsoem Ali, Olivier R Busch, Michail Doukas, Ignace H J T de Hingh, Misha D P Luyer, Vincent E de Meijer, J Sven D Mieog, Martijn Stommel, Bas Groot Koerkamp, Lydia G van der Geest, Marc G Besselink
Förderung
- DIPLOMA-2 × 2
- Intuitive Foundation
- KWF Dutch Cancer Society
- Intuitive Surgical Inc
Zitieren
APA
Menso, J. E., Bruna, C. L., Ali, M., Bonsing, B., Bosscha, K., Brosens, L. A. A., Busch, O. R., Crobach, A. S. L. P., Daams, F., Derksen, W., Dewulf, M. J. L., Doukas, M., Fariña Sarasqueta, A., Festen, S., Abu Hilal, M., de Hingh, I. H. J. T., Homs, M. Y. V., Kazemier, G., Lips, D. J., …, & Besselink, M. G. (2025). Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis. British Journal of Surgery. https://doi.org/10.1093/bjs/znaf153
Vancouver
Menso JE, Bruna CL, Ali M, Bonsing B, Bosscha K, Brosens LAA, et al. Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis. British Journal of Surgery. 2025. doi:10.1093/bjs/znaf153
BibTeX
@article{Menso2025,
author = {Menso, Julia E and Bruna, Caro L and Ali, Mahsoem and Bonsing, Bert and Bosscha, Koop and Brosens, Lodewijk A A and Busch, Olivier R and Crobach, A Stijn L P and Daams, Freek and Derksen, Wouter and Dewulf, Maxime J L and Doukas, Michail and Fariña Sarasqueta, Arantza and Festen, Sebastiaan and Abu Hilal, Mohammad and de Hingh, Ignace H J T and Homs, Marjolein Y V and Kazemier, Geert and Lips, Daan J and Luyer, Misha D P and de Meijer, Vincent E and Mieog, J Sven D and Te Riele, Wouter W and van Santvoort, Hjalmar C and van der Schelling, George P and Stommel, Martijn and Verheij, Joanne and de Wilde, Roeland F and Wilmink, Johanna W and Molenaar, I Quintus and Groot Koerkamp, Bas and van der Geest, Lydia G and Besselink, Marc G},
title = {Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis},
journal = {British Journal of Surgery},
year = {2025},
doi = {10.1093/bjs/znaf153}
}
EUVIMED